BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21569454)

  • 1. Reduced CSF turnover and decreased ventricular Aβ42 levels are related.
    Serot JM; Peltier J; Fichten A; Ledeme N; Bourgeois AM; Jouanny P; Toussaint P; Legars D; Godefroy O; Mazière JC
    BMC Neurosci; 2011 May; 12():42. PubMed ID: 21569454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
    J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
    Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
    Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
    Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V
    PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
    Jingami N; Uemura K; Asada-Utsugi M; Kuzuya A; Yamada S; Ishikawa M; Kawahara T; Iwasaki T; Atsuchi M; Takahashi R; Kinoshita A
    J Alzheimers Dis; 2019; 72(1):271-277. PubMed ID: 31561378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of Alzheimer's Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Vanninen A; Tesseur I; Pemberton D; Van Der Ark P; Kokkola T; Herukka SK; Rauramaa T; Hiltunen M; Blennow K; Zetterberg H; Leinonen V
    J Alzheimers Dis; 2023; 91(1):305-319. PubMed ID: 36404546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular volume in relation to lumbar CSF levels of amyloid-β 1-42, tau and phosphorylated tau in iNPH, is there a dilution effect?
    Lidén S; Farahmand D; Laurell K
    Fluids Barriers CNS; 2022 Jul; 19(1):59. PubMed ID: 35843939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
    Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
    J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus.
    Brandner S; Thaler C; Lelental N; Buchfelder M; Kleindienst A; Maler JM; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2014; 41(4):1057-62. PubMed ID: 24748118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
    Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
    J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease.
    Manniche C; Simonsen AH; Hasselbalch SG; Andreasson U; Zetterberg H; Blennow K; Høgh P; Juhler M; Hejl AM
    J Alzheimers Dis; 2020; 75(3):937-947. PubMed ID: 32390628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
    Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Rauramaa T; Nagga K; Leinonen V; Tullberg M
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
    J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of amyloid PET scan in normal pressure hydrocephalus.
    Jang H; Park SB; Kim Y; Kim KW; Lee JI; Kim ST; Lee KH; Kang ES; Choe YS; Seo SW; Kim HJ; Kim YJ; Yoon CW; Na DL
    J Neurol; 2018 Jan; 265(1):63-73. PubMed ID: 29128930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tissue Aβ42 levels are linked to shunt response in idiopathic normal pressure hydrocephalus.
    Abu Hamdeh S; Virhammar J; Sehlin D; Alafuzoff I; Cesarini KG; Marklund N
    J Neurosurg; 2018 Jan; 130(1):121-129. PubMed ID: 29350601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes.
    Jurjević I; Miyajima M; Ogino I; Akiba C; Nakajima M; Kondo A; Kikkawa M; Kanai M; Hattori N; Arai H
    J Alzheimers Dis; 2017; 56(1):317-325. PubMed ID: 27911315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K; Ko PW; Jin M; Suk K; Lee HW
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.
    Santangelo R; Cecchetti G; Bernasconi MP; Cardamone R; Barbieri A; Pinto P; Passerini G; Scomazzoni F; Comi G; Magnani G
    J Alzheimers Dis; 2017; 60(1):183-200. PubMed ID: 28826180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
    Craven CL; Baudracco I; Zetterberg H; Lunn MPT; Chapman MD; Lakdawala N; Watkins LD; Toma AK
    Acta Neurochir (Wien); 2017 Dec; 159(12):2293-2300. PubMed ID: 28889317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.
    Herukka SK; Rummukainen J; Ihalainen J; von Und Zu Fraunberg M; Koivisto AM; Nerg O; Puli LK; Seppälä TT; Zetterberg H; Pyykkö OT; Helisalmi S; Tanila H; Alafuzoff I; Hiltunen M; Rinne J; Soininen H; Jääskeläinen JE; Leinonen V
    J Alzheimers Dis; 2015; 46(1):261-9. PubMed ID: 25720406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.